Patients with Huntington’s disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population.
Northwestern Medicine scientists have discovered why Huntington’s is so toxic to cancer cells and harnessed it for a novel approach to treat cancer, a new study reports.
Huntington’s is caused by an over abundance of a certain type of repeating RNA sequences in one gene, huntingtin, present in every cell. The defect that causes the disease also is highly toxic to tumor cells. These repeating sequences — in the form of so-called small interfering RNAs — attack genes in the cell that are critical for survival. Nerve cells in the brain are vulnerable to this form of cell death, however, cancer cells appear to be much more susceptible.
“This molecule is a super assassin against all tumor cells,” said senior author Marcus Peter, the Tom D. Spies Professor of Cancer Metabolism at Northwestern University Feinberg School of Medicine. “We’ve never seen anything this powerful.”
Huntington’s disease deteriorates a person’s physical and mental abilities during their prime working years and has no cure.
The study will be published Feb. 12 in the journal EMBO Reports.
To test the super assassin molecule in a treatment situation, Peter collaborated with Dr. Shad Thaxton, associate professor of urology at Feinberg, to deliver the molecule in nanoparticles to mice with human ovarian cancer. The treatment significantly reduced the tumor growth with no toxicity to the mice, Peter said. Importantly, the tumors did not develop resistance to this form of cancer treatment.
Peter and Thaxton are now refining the delivery method to increase its efficacy in reaching the tumor. The other challenge for the scientists is figuring out how to stabilize the nanoparticles, so they can be stored.
First and co-corresponding author Andrea Murmann, research assistant professor in medicine at Feinberg, also used the molecule to treat human and mouse ovarian, breast, prostate, liver, brain, lung, skin and colon cancer cell lines. The molecule killed all cancer cells in both species.
The Huntington’s cancer weapon was discovered by Murmann, who had worked with Peter on earlier research that identified an ancient kill-switch present in all cells that destroys cancer.
“I thought maybe there is a situation where this kill switch is overactive in certain people, and where it could cause loss of tissues,” Murmann said. “These patients would not only have a disease with an RNA component, but they also had to have less cancer.”
She started searching for diseases that have a lower rate of cancer and had a suspected contribution of RNA to disease pathology. Huntington’s was the most prominent.
When she looked at the repeating sequences in huntingtin, the gene that causes the disease, she saw a similar composition to the earlier kill switch Peter had found. Both were rich in the C and G nucleotides (molecules that form the building blocks of DNA and RNA).
“Toxicity goes together with C and G richness,” Murmann said. “Those similarities triggered our curiosity.”
In the case of people who have Huntington’s, the gene huntingtin has too many repeating sequences of the triplet sequence CAG. The longer the repeating sequence, the earlier they will develop the disease.
“We believe a short-term treatment cancer therapy for a few weeks might be possible, where we could treat a patient to kill the cancer cells without causing the neurological issues that Huntington’s patients suffer from,” Peter said.
Peter also is co-leader of the Translational Research in Solid Tumors Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Huntington’s patients have a lifetime exposure to these toxic RNA sequences, but generally don’t develop symptoms of the disease until age 40, he noted.
Every child of a parent with Huntington’s has 50/50 chance of carrying the faulty gene. Today, there are approximately 30,000 symptomatic Americans and more than 200,000 at-risk of inheriting the disease.
Learn more: Huntington’s disease provides new cancer weapon
The Latest on: Cancer therapy
The family battling debt and depression to get treatment for 18-month-old's rare cancer
on May 23, 2018 at 12:10 pm
The parents of a 18-month-old baby with an aggressive form of cancer have been left facing huge amounts of debt after they had to give up work to care for her. Kendall Julie Jolley, was diagnosed with rhabdomyosarcoma, a rare form of soft tissue cancer in ... […]
Global T-Cell Immunotherapy Market Growing Rapidly In Coming Years For Advanced Stage Cancer Treatment
on May 23, 2018 at 5:56 am
A new market study, titled “Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis”, has been featured on WiseGuyReports. Cancer is a class of disease which is classified by an uncontrolled cell growth. There are various types of cancer ... […]
Potential Treatment for Triple-Negative Breast Cancer
on May 23, 2018 at 1:10 am
Recent research published in the Journal of Clinical Investigation examined the drug Dacogen (decitabine), which was observed to target the growth of cancer and was effective in treating tumors resistant to chemotherapy. The Food and Drug Administration ... […]
Capitals' fan undergoing cancer treatment rocks the red in hospital room
on May 22, 2018 at 4:16 pm
Amanda Wilson loves her Capitals. She watched Monday night's game from a hospital room at the Mayo Clinic in Rochester, MN. She texted, "the entire team put everything they had into that game. They left nothing behind." Way to go Caps!! Watching from my ... […]
Treatment Options for Blood Cancer Patients Conference Review
on May 22, 2018 at 2:49 pm
The 14th Annual Treatment Options for Blood Cancer Patients Conference, was successfully held at the Hyatt Regency in Lisle, Ill. on Saturday, May 19. The conference was presented by the Leukemia Research Foundation (LRF), the Cardinal Bernardin Cancer ... […]
Cancer patients are twice as likely to declare bankruptcy
on May 22, 2018 at 8:29 am
Josephine Rizo survived chemotherapy, surgery and radiation, but breast cancer treatment wrecked her finances. Money was already tight when doctors told the Phoenix resident she had an aggressive form of the disease. Then she took a pay cut after going on ... […]
Many cancer patients juggle care along with financial pain
on May 22, 2018 at 8:07 am
In this April 13, 2018, photo Josephine Rizo sits in her home with her stack of bills from her ongoing battle with cancer in Phoenix. As treatment costs soar and insurance coverage shrinks, hospitals and patient advocates around the U.S. are rushing to ... […]
Resetting the epigenetic balance for cancer therapy
on May 22, 2018 at 3:57 am
Though mutations in a gene called MLL3 are common across many types of cancers, their relationship to the development of the disease has been unclear. Now, a Northwestern Medicine study has identified an epigenetic imbalance that silences the expression of ... […]
More men with low-risk prostate cancer are rejecting aggressive treatment, new study suggests
on May 22, 2018 at 3:31 am
A sea change is occurring among men with low-risk prostate cancer: Increasing numbers are avoiding immediate surgery or radiation and are opting instead for close monitoring of the disease to see whether it worsens. The shift is sharply reducing ... […]
New life-saving cancer treatment tied to vision loss
on May 20, 2018 at 1:01 pm
SUNDAY, May 20, 2018 -- A newer type of cancer treatment may offer the chance of longer survival, but the drugs could also trigger new side effects, such as vision problems. New research reports on three cases of a potentially vision-threatening eye ... […]
via Google News and Bing News